Glaukos Corp
Change company Symbol lookup
Select an option...
GKOS Glaukos Corp
CAC Camden National Corp
RE Everest Re Group Ltd
URRNF Twenty Seven Co Ltd
TWLV Twelve Seas Investment Co II
FLO Flowers Foods Inc
CAJ Canon Inc
WPC WP Carey Inc
PPT Putnam Premier Income Trust
GME GameStop Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that is focused on developing therapies for the treatment of glaucoma, corneal disorders, and retinal disease. The Company’s products are designed to treat mild-to-moderate open-angle glaucoma, the iStent, the iStent inject, and the iStent inject W. The Company’s Micro-Invasive Glaucoma Surgery (MIGS) serves as an alternative to the traditional glaucoma treatment paradigm. It offers bio-activated pharmaceutical therapy for the treatment of corneal disorder and keratoconus. It is also developing a pipeline of surgical devices, sustained pharmaceutical therapies, implantable biosensors intended to treat glaucoma progression, corneal disorders such as keratoconus, dry eye, refractive vision correction, retinal diseases such as neovascular age-related macular degeneration, diabetic macular edema and retinal vein occlusion.

Closing Price
$51.59
Day's Change
3.04 (6.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
51.62
Day's Low
47.19
Volume
(Light)
Volume:
431,397

10-day average volume:
587,920
431,397
  • Prev Close
    48.55
  • Today's Open
    48.23
  • Day's Range
    47.19-51.62
  • Avg Vol (10-day)
    587.9K
  • Last (time)
    7:00p ET 01/28/22
  • Last (size)
    100
  • 52-Wk Range
    39.35 - 99.00
    LowHigh
  • (03/02/21 - 12/03/21)
    31.11%
  • 56.5%
  • Market Cap
    2.4B
  • Shares Outstanding
    46.9M
  • -0.85
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 92.02
  • (% of float 01/14/22)
    3.28

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.